Quantcast
Connect with us

Bayer clinches $66 billion takeover of Monsanto

Published

on

German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of around $66 billion, ending months of wrangling after increasing its bid for a third time.

The $128 a share deal, up from Bayer’s previous offer of $127.50 a share, is the biggest of the year so far and the largest cash bid on record.

The deal will create a company commanding more than a quarter of the combined world market for seeds and pesticides in the fast-consolidating farm supplies industry.

ADVERTISEMENT

However, competition authorities are likely to scrutinize the tie-up closely, and some of Bayer’s own shareholders have been highly critical of a takeover plan which they say risks overpaying and neglecting the company’s pharmaceutical business.

The transaction includes a break-fee of $2 billion that Bayer will pay to Monsanto should it fail to get regulatory clearance. Bayer expects the deal to close by the end of 2017.

The details confirm what a source close to the matter told Reuters earlier.

Bernstein Research analysts said on Tuesday they saw only a 50 percent chance of the deal winning regulatory clearance, although they cited a survey among investors that put the likelihood at 70 percent on average

“We believe political pushback to this deal, ranging from farmer dissatisfaction with all their suppliers consolidating in the face of low farm net incomes to dissatisfaction with Monsanto leaving the United States, could provide significant delays and complications,” they wrote in a research note.

ADVERTISEMENT

Bayer said it was offering a 44 percent premium to Monsanto’s share price on May 9, the day before it made its first written proposal.

It plans to raise $19 billion to help fund the deal by issuing convertible bonds and new shares to its existing shareholders, and said banks had also committed to providing $57 billion of bridge financing.

At 1140 GMT, Bayer shares were up 2.2 percent at 95.32 euros. Monsanto’s were up 0.2 percent at $106.3 in premarket trade.

ADVERTISEMENT

ONE-STOP SHOP

Bayer’s move to combine its crop chemicals business, the world’s second largest after Syngenta AG, with Monsanto’s industry leading seeds business, is the latest in a series of major tie-ups in the agrochemicals sector.

The German company is aiming to create a one-stop shop for seeds, crop chemicals and computer-aided services to farmers. That was also the idea behind Monsanto’s swoop on Syngenta last year, which the Swiss company fended off, only to agree later to a takeover by China’s state-owned ChemChina. Elsewhere in the industry, U.S. chemicals giants Dow Chemical and DuPont plan to merge and later spin off their respective seeds and crop chemicals operations into a major agribusiness. The Bayer-Monsanto deal will be the largest ever involving a German buyer, beating Daimler’s tie-up with Chrysler in 1998, which valued the U.S. carmaker at more than $40 billion. It will also be the largest all-cash transaction on record, ahead of brewer InBev’s $60.4 billion offer for Anheuser-Busch in 2008.

ADVERTISEMENT

Bayer said it expected the deal to boost its core earnings per share in the first full year following completion, and by a double-digit percentage in the third year.

Bayer and Monsanto were in talks to sound out ways to combine their businesses as early as March, which culminated in Bayer coming out with an initial $122 per-share takeover proposal in May.

Antitrust experts have said regulators will likely demand the sale of some soybeans, cotton and canola seed assets as a condition for approving the deal.

ADVERTISEMENT

Bayer said BofA Merrill Lynch, Credit Suisse, Goldman Sachs, HSBC and JP Morgan had committed to providing the bridge financing.

BofA Merrill Lynch and Credit Suisse are acting as lead financial advisers to Bayer, with Rothschild as an additional adviser. Bayer’s legal advisers are Sullivan & Cromwell LLP and Allen & Overy LLP.

Morgan Stanley and Ducera Partners are acting as financial advisers to Monsanto, with Wachtell, Lipton, Rosen & Katz its legal adviser.

(Editing by Maria Sheahan and Mark Potter)

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

2020 Election

Expert: Trump’s ‘forward-leaning posture’ and ‘body tics’ are cause for serious concern

Published

on

A professor of Neurology at George Washington University says he believes there may be legitimate concerns over President Donald J. Trump's "forward-listing posture" that goes beyond the comical memes and gif responses normally shared on social media.

"I know something about political figures and observable signs of illness from afar," Richard E. Cytowic M.D. wrote in Psychology Today. "... The American public deserves an accurate account of our president’s health."

Continue Reading

2020 Election

Armed guards at Florida polling site say they were sent by the Trump campaign

Published

on

Two armed men set up a tent outside of an early voting location in St. Petersberg, Florida, saying that they were the Trump campaign.

"The Sheriff [Bob Gualtieri] told me the persons that were dressed in these security uniforms had indicated to sheriff's deputies that they belonged to a licensed security company and they indicated, and this has not been confirmed yet, that they were hired by the Trump campaign," said Pinellas County Supervisor of Elections Julie Marcus.

"The sheriff and I take this very seriously," Marcus said. "Voter intimidation, deterring voters from voting, impeding a voter's ability to cast a ballot in this election is unacceptable and will not be tolerated in any way shape, or form. So we anticipated many things going into this election. Not only cybersecurity, but physical security, and we had a plan in place and executed that plan."

Continue Reading
 

Breaking Banner

Seth Meyers says Trump is so checked out he sounds like he’s already packing his stuff

Published

on

President Donald Trump's closing message on his 2020 campaign career appears to be "'60 Minutes' was mean to me," and he doesn't really want to be in the White House anymore, said Seth Meyers during his "Closer Look" segment Wednesday.

Speaking about Trump's recent decision to walk out of a "60 Minutes" interview, Myers noted that it doesn't appear that Trump's heart is really in it anymore. Apparently, presidenting is no longer for once you start getting indicted.

"You can almost picture him on the other end of the phone in the White House packing his things in a cardboard box, not really paying attention, making half-hearted sh*t up because he knows it's what they want to hear," said Meyers.

Continue Reading
 
 
Democracy is in peril. Invest in progressive news. Join Raw Story Investigates for $1. Go ad-free. LEARN MORE